Theravance Biopharma, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12B
10-12B/A
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
PRE 14A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001193125-26-124073 | Mar 25, 2026 | — |
| 10-K | 10-K | 0001104659-26-033077 | Mar 23, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001104659-26-031795 | Mar 19, 2026 | — |
| 4 | — | 0001898490-26-000004 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001950047-26-002634 | Mar 16, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-022572 | Mar 3, 2026 | — |
| 4 | — | 0001302443-26-000002 | Feb 24, 2026 | Feb 20, 2026 |
| 4 | — | 0001966698-26-000002 | Feb 24, 2026 | Feb 20, 2026 |
| 4 | — | 0002012524-26-000002 | Feb 24, 2026 | Feb 20, 2026 |
| 4 | — | 0001898490-26-000002 | Feb 24, 2026 | Feb 20, 2026 |
| 4 | — | 0001961289-26-000002 | Feb 24, 2026 | Feb 20, 2026 |
| SCHEDULE 13G/A | — | 0001493152-26-007116 | Feb 17, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-002726 | Jan 12, 2026 | — |
| 8-K | FORM 8-K | 0001104659-25-119032 | Dec 8, 2025 | — |
| 4 | — | 0001898490-25-000008 | Dec 5, 2025 | Dec 3, 2025 |
| 144 | — | 0001950047-25-009691 | Dec 3, 2025 | — |
| 4 | — | 0001256230-25-000009 | Dec 1, 2025 | Nov 26, 2025 |
| 144 | — | 0001950047-25-009394 | Nov 26, 2025 | — |
| 4 | — | 0001966698-25-000006 | Nov 24, 2025 | Nov 20, 2025 |
| 4 | — | 0002012524-25-000006 | Nov 24, 2025 | Nov 20, 2025 |
| 4 | — | 0001961289-25-000006 | Nov 24, 2025 | Nov 20, 2025 |
| 4 | — | 0001898490-25-000006 | Nov 24, 2025 | Nov 20, 2025 |
| 4 | — | 0001302443-25-000008 | Nov 21, 2025 | Nov 19, 2025 |
| 4/A | — | 0001256230-25-000007 | Nov 14, 2025 | Nov 11, 2025 |
| 4 | — | 0001256230-25-000006 | Nov 13, 2025 | Nov 11, 2025 |
| 10-Q | 10-Q | 0001104659-25-110382 | Nov 12, 2025 | Sep 30, 2025 |
| 144 | — | 0001950047-25-008708 | Nov 12, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-109146 | Nov 10, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-082048 | Aug 25, 2025 | — |
| 4 | — | 0001415889-25-022801 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022803 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022799 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022794 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022797 | Aug 22, 2025 | Aug 20, 2025 |
| 8-K | FORM 8-K | 0001104659-25-080470 | Aug 20, 2025 | Aug 15, 2025 |
| 10-Q | 10-Q | 0001558370-25-011408 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001104659-25-076837 | Aug 12, 2025 | — |
| 4 | — | 0001415889-25-019869 | Jul 16, 2025 | Jul 14, 2025 |
| 144 | — | 0001950047-25-004985 | Jul 14, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-062722 | Jun 26, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-018221 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-017585 | Jun 17, 2025 | Jun 13, 2025 |
| 8-K | FORM 8-K | 0001104659-25-056996 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-015642 | Jun 4, 2025 | Jun 2, 2025 |
| 8-K | FORM 8-K | 0001104659-25-055100 | Jun 2, 2025 | May 30, 2025 |
| 144 | — | 0001950047-25-003658 | Jun 2, 2025 | — |
| 4 | — | 0001415889-25-014257 | May 22, 2025 | May 20, 2025 |
| 4 | — | 0001415889-25-014259 | May 22, 2025 | May 20, 2025 |
| 4 | — | 0001415889-25-014261 | May 22, 2025 | May 20, 2025 |
| 4 | — | 0001415889-25-014263 | May 22, 2025 | May 20, 2025 |